PWMAG
GILD icon

Pinnacle Wealth Management Advisory Group’s Gilead Sciences GILD Stock Holding History

Pinnacle Wealth Management Advisory Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.65M Buy
33,382
+1,138
+4% +$159K 0.32% 70
2025
Q4 		$3.96M Sell
32,244
-4,369
-12% -$531K 0.27% 79
2025
Q3 		$4.06M Buy
36,613
+1,732
+5% +$197K 0.31% 70
2025
Q2 		$3.87M Buy
34,881
+506
+1% +$53.9K 0.32% 69
2025
Q1 		$3.85M Buy
34,375
+677
+2% +$69.9K 0.36% 65
2024
Q4 		$3.11M Buy
33,698
+2,580
+8% +$232K 0.29% 73
2024
Q3 		$2.61M Sell
31,118
-36
-0.1% -$2.75K 0.25% 82
2024
Q2 		$2.14M Buy
31,154
+13,765
+79% +$919K 0.22% 88
2024
Q1 		$1.27M Buy
17,389
+2,061
+13% +$158K 0.14% 114
2023
Q4 		$1.24M Buy
15,328
+561
+4% +$43.7K 0.15% 102
2023
Q3 		$1.11M Buy
14,767
+30
+0.2% +$2.31K 0.14% 107
2023
Q2 		$1.14M Sell
14,737
-381
-3% -$30.4K 0.14% 109
2023
Q1 		$1.25M Sell
15,118
-2,291
-13% -$190K 0.17% 99
2022
Q4 		$1.49M Buy
17,409
+480
+3% +$38K 0.22% 89
2022
Q3 		$1.04M Sell
16,929
-957
-5% -$60.3K 0.17% 101
2022
Q2 		$1.11M Buy
17,886
+3,120
+21% +$193K 0.18% 99
2022
Q1 		$878K Buy
14,766
+856
+6% +$54.7K 0.13% 133
2021
Q4 		$1.01M Buy
13,910
+907
+7% +$62.5K 0.17% 120
2021
Q3 		$908K Sell
13,003
-69
-0.5% -$4.85K 0.21% 103
2021
Q2 		$900K Sell
13,072
-236
-2% -$15.8K 0.21% 105
2021
Q1 		$860K Buy
13,308
+5,935
+80% +$383K 0.24% 90
2020
Q4 		$430K Sell
7,373
-2,741
-27% -$165K 0.13% 125
2020
Q3 		$639K Buy
10,114
+3,220
+47% +$223K 0.22% 100
2020
Q2 		$530K Buy
6,894
+845
+14% +$64.8K 0.2% 106
2020
Q1 		$452K Buy
6,049
+275
+5% +$19K 0.22% 98
2019
Q4 		$375K Sell
5,774
-90
-2% -$5.86K 0.14% 132
2019
Q3 		$372K Buy
5,864
+120
+2% +$7.84K 0.16% 123
2019
Q2 		$388K Sell
5,744
-2,495
-30% -$164K 0.17% 124
2019
Q1 		$536K Buy
8,239
+2,895
+54% +$192K 0.24% 99
2018
Q4 		$334K Sell
5,344
-1,350
-20% -$94.4K 0.18% 122
2018
Q3 		$517K Buy
6,694
+160
+2% +$12.1K 0.26% 97
2018
Q2 		$463K Buy
6,534
+1,130
+21% +$79.8K 0.25% 95
2018
Q1 		$407K Buy
5,404
+450
+9% +$35.8K 0.23% 97
2017
Q4 		$355K Sell
4,954
-259
-5% -$19.7K 0.2% 103
2017
Q3 		$422K Buy
5,213
+200
+4% +$15.3K 0.25% 96
2017
Q2 		$355K Buy
5,013
+725
+17% +$48.2K 0.22% 105
2017
Q1 		$291K Sell
4,288
-910
-18% -$64K 0.2% 101
2016
Q4 		$372K Sell
5,198
-570
-10% -$42.4K 0.27% 86
2016
Q3 		$456K Sell
5,768
-2,125
-27% -$173K 0.35% 78
2016
Q2 		$658K Buy
7,893
+270
+4% +$24K 0.52% 62
2016
Q1 		$700K Buy
7,623
+554
+8% +$50K 0.62% 57
2015
Q4 		$715K Buy
7,069
+500
+8% +$52K 0.65% 55
2015
Q3 		$645K Buy
+6,569
New +$730K 0.62% 51

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group's GILD Position: Q1 2026 in Review

Pinnacle Wealth Management Advisory Group increased its Gilead Sciences (GILD) stake by 3.5% in Q1 2026, buying an estimated $159K and bringing the position to 33,382 shares worth $4.65M. The position accounts for 0.32% of the portfolio, ranked #70.

Pinnacle Wealth Management Advisory Group first reported a position in GILD in Q3 2015 and has held it in 43 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Pinnacle Wealth Management Advisory Group held 33,382 shares of Gilead Sciences worth $4.65M as of Q1 2026.
  • Pinnacle Wealth Management Advisory Group bought 1,138 Gilead Sciences shares in Q1 2026, an estimated $159K.
  • Gilead Sciences made up 0.32% of Pinnacle Wealth Management Advisory Group's portfolio in Q1 2026, its #70 holding.
  • Pinnacle Wealth Management Advisory Group first reported a position in Gilead Sciences in Q3 2015 and has held it in 43 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q1 2026, filed 21 Apr 2026.